title: Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.
authors.forename: Ewout M
authors.initials: EM
authors.lastname: Baerveldt
authors.forename: Jasper H
authors.initials: JH
authors.lastname: Kappen
authors.forename: H Bing
authors.initials: HB
authors.lastname: Thio
authors.forename: Jan Am
authors.initials: JA
authors.lastname: van Laar
authors.forename: P Martin
authors.initials: PM
authors.lastname: van Hagen
authors.forename: Errol P
authors.initials: EP
authors.lastname: Prens
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D002675:Child, Preschool; D005260:Female; D017497:Hidradenitis Suppurativa / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D000069549:Ustekinumab
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069549:Ustekinumab